Publications

Dr. Koonin has published 100+ peer-reviewed papers; these papers have been cited over 10,000 times by other scientsts. Several of these are listed below:

COVID-19

• Koonin LM, Roszak SE, McFeely KM. Building on Success Serving the Nation: Codifying Key Pharmacy Practice Authorities Beyond COVID-19. Health Secur. 2023 May 10. doi: 10.1089/hs.2023.0085. Epub ahead of print. PMID: 37162527.

• SteelFisher GK, McMurtry CL, Caporello HL, Lubell K, Koonin LM et al. Video Telemedicine Experiences In COVID-19 Were Positive, But Physicians and Patients Prefer In-Person Care For The Future. Health Affairs. 2023:42(4) 575-584

• Shah A, Oyegun E, Hampton W, Neri A, Maddox N, Raso D, Sandhu P, Patel A, Koonin L, et al. Engagement with the Centers for Disease Control and Prevention Coronavirus Self-Checker and Guidance Provided to Users in the United States From March 23, 2020, to April 19, 2021: Thematic and Trend Analysis. J Med Internet Res 2023;25:e39054

• Return to the Workplace during the COVID-19 Pandemic: A Framework to Inform Business Decision-making. Koonin, LM. J Bus Contin Emer Plan: 2022;16(1) 62-72.

• Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020. Koonin LM, Hoots B, Tsang CA, et al. MMWR Morbidity and Mortality Weekly Report. 2020;69:1595–1599.

• Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans. Koonin LM. Journal of Business Continuity and Emergency Planning. 13(4):1-15. 2020.

• A Social and Behavioral Research Agenda to Facilitate COVID-19 Vaccine Uptake in the United States. Brunson EK, Schoch-Spana M, on behalf of the Working Group on Readying Populations for COVID-19 Vaccine: Health Security.;18(4). 2020. Served on the Working Group.

• Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020. Patel A, Jernigan DB. MMWR Morbidity and Mortality Weekly Report 2020;69:140–146.

• The Public’s Role in COVID-19 Vaccination: Planning Recommendations Informed by Design Thinking and the Social, Behavioral, and Communication Sciences. Schoch-Spana M, Brunson E, Long R, Ravi S, Ruth A, Trotochaud M on behalf of the Working Group on Readying Populations for COVID-19 Vaccine. Baltimore, MD: Johns Hopkins Center for Health Security; 2021. Served on the Working Group.

PANDEMIC PLANNING AND RESPONSE

• Koonin LM, Yassanye D. How Employers Impact Individual and Community Health During Public Health Emergencies: Rationale for Public Health/Private Sector Partnerships. Health Secur. 2024 May 3. doi: 10.1089/hs.2023.0123. Epub ahead of print. PMID: 38700551.

• Koonin LM. A Missing Link in Public Health Preparedness and Emergency Response: Engaging Private Sector Employers for Pandemic Workplace Policies. Commentary. Health Security. 2023:21(6) 473-478. doi: 10.1089/hs.2023.0031. Epub ahead of print. PMID: 37552815.

• An Assessment of State Laws Providing Gubernatorial Authority to Remove Legal Barriers to Emergency Response. Sunshine G, Thompson K, Menon AN, Anderson N, Penn M, Koonin LM. Health Security. 17:(2):156-161. 2019.

• 100 years since 1918: Medical  Countermeasures and Pandemic Influenza Preparedness. Jester B, Uyeki T, Patel A, Koonin LM, Jernigan D.  American Journal of Public Health. 108(11):1469-1472. 2018.​

• Interim updated planning guidance on allocating and targeting pandemic influenza vaccine during an influenza pandemic. Centers for Disease Control and Prevention. 2018.

• Updated preparedness and response framework for influenza pandemics. Holloway R, Rasmussen SA, Zaza S, Cox N, Jernigan DB, with the Influenza Pandemic Framework Workgroup. MMWR Recommendations and Reports. 2014 Sep 26;63(RR-06):1-9. 2018.

• Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Reed C, Biggerstaff M, Finelli L, Koonin LM, et. al. Emerging Infectious Diseases. 19(1):85-91. 2013.

   

• Exploring National Surveillance for Health-Related Workplace Absenteeism: Lessons Learned From the 2009 Influenza A Pandemic. Groenewold, MR, Konicki DL, Luckhaupt SE, Gomaa A, Koonin LM. Disaster Medicine and Public Health Preparedness. 7(2):160-166. 2013.

• Koonin LM. (Guest Columnist). During the H1N1 pandemic, please allow sick workers to stay home. University of Minnesota’s CIDRAP Business Source. 2009 Sept.

• Centers for Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States; 2007 Feb. (no authors listed by name, one of three lead authors). National pandemic policy posted on CDC’s website.

PHARMACIES AS EMERGENCY RESPONSE PARTNERS

• Koonin LM, Roszak SE, McFeely KM. Building on Success Serving the Nation: Codifying Key Pharmacy Practice Authorities Beyond COVID-19. Health Secur. 2023 May 10. doi: 10.1089/hs.2023.0085. Epub ahead of print. PMID: 37162527

• NACDS and Health Preparedness Partners, LLC. (co-author) Community Retail Pharmacies’ Experience during the COVID-19 Response: Successes and Lessons Learned to Date. November, 2021. NACDS. Monograph.

• Scripted Surge Pharmacy Pandemic Exercise: Testing Vaccine Administration and Antiviral Dispensing. Sokolow LZ, Patel A, Koonin LM, Graitcer SB. Health Security. 16(4):262-273. 2018. 

• Pharmacist Views on Alternative Methods for Antiviral Distribution and Dispensing During an Influenza Pandemic. SteelFisher GK, Benson JM, Caporello H, Koonin LM, Patel A, Ben-Porath E, Blendon RJ. Health Security. 16(2):108-118. 2018. 

• Public Views on Alternative Methods for Antiviral Distribution and Dispensing During an Influenza Pandemic. SteelFisher GK, Caporello H, Patel A, Koonin LM. Health Security.16 (6): 2018.

• CDC's 2009 H1N1 vaccine pharmacy initiative in the United States: implications for future public health and pharmacy collaborations for emergency response. Koonin LM, Beauvais DR, Shimabukuro T, Wortley PM, Palmier JB, Stanley TR, Theofilos J, Merlin TL. Disaster Med and Public Health Preparedness. 2011 Dec;5(4):253-5. 2011. 

• Leveraging partnerships among community pharmacists, pharmacies, and health departments to improve pandemic influenza response. Rubin SE, Schulman RM, Roszak AR, Herrmann J, Patel A, Koonin LM. Biosecurity and Bioterrorism. 2014 Mar-Apr;12(2):76-84. 2014.

• Place of Influenza Vaccination Among Adults-United States, 2010-11 Influenza Season. Kennedy ED, Santibanez TA, Bridges CB, Wortley PM, Koonin LM. MMWR Morbidity and Mortality. Weekly Report. 60(23). 781-785. 2011. 

NON-PHARMACEUTICAL MEASURES

• Community mitigation guidelines to prevent pandemic influenza—United States, 2017. Qualls, NL, Levitt, AM, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, Reed C, Uzicanin A, and Working Group (L Koonin). MMWR Recommendations and Reports. 66(RR-1). 2017.

• Selecting nonpharmaceutical strategies to minimize influenza spread: the 2009 influenza A (H1N1) pandemic and beyond. Barrios LC, Koonin LM, Kohl KS, Cetron M. Public Health Reports.127(6):565-71. 2012.

• School closure to reduce influenza transmission. Koonin LM, Cetron MS. Letter to the Editor. Emerging Infectious Diseases, 15(1):137-138. 2009.

• Centers for Disease Control and Prevention. CDC Guidance for Businesses and Employers to Plan and Respond to the 2009–2010 Influenza Season. (Senior author). 2009 Aug. Guidance posted for businesses posted on CDC’s website during the 2009 H1N1 Pandemic.

• Public response to community mitigation measures for pandemic influenza. Blendon RJ, Koonin LM, Benson J, Cetron MS, Pollard WE, Mitchell EW, Weldon KJ, Herrmann MJ. Emerging Infectious Diseases. 14(5):778-786. 2008.

MEDICAL COUNTERMEASURES

• Strategies to inform allocation of stockpiled ventilators to healthcare facilities during a pandemic. Koonin LM, Pillai S, Kahn EB, Moulia D, Patel A. Health Security.;18(2). 2020.

• A Control Banding Framework for Protecting the US Workforce from Aerosol Transmissible Infectious Disease Outbreaks with High Public Health Consequences. Sietsema M, Radonovich L, Hearl FJ, Fisher EM, Brosseau LM, Shaffer RE, Koonin LM. Health Security. 17:(2):124-132. 2019. This paper was nominated for the 2020 CDC Charles C. Shepard Science Awards.

• 100 years since 1918: Medical  Countermeasures and Pandemic Influenza Preparedness. Jester B, Uyeki T, Patel A, Koonin LM, Jernigan D.  American Journal of Public Health. 108(11):1469-1472. 2018.

• Timely Antiviral Administration During an Influenza Pandemic: Key Components. Koonin LM, Patel A. American Journal of Public Health. 108(S3):S215-S220. 2018.

• Public Views on Alternative Methods for Antiviral Distribution and Dispensing During an Influenza Pandemic. SteelFisher GK, Caporello H, Patel A, Koonin LM, McGowan E, Ben-Porath E, Blendon RJ.  Health Security 16:(6):365-380. 2018.

   

• Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. O'Hagan JJ, Wong KK, Campbell AP, Patel A, Swerdlow DL, Fry AM, Koonin LM, Meltzer MI. Clinical Infectious Diseases. 60(0 1):S30-S41. 2015.

   

• Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic. Meltzer, MI., Patel A, Ajao A, Nystrom SV, Koonin LM - Clinical Infectious Diseases. 60(1):S52-S57. 2015.

   

• Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency. Ajao A, Nystrom SV, Koonin LM, Patel A, Howell DR, Baccam P, Lant T, Malatino E, Chamberlin M, Meltzer MI. Disaster Medicine and Public Health Preparedness. 9(6):634-641. 2015.

• Potential demand for respirators and surgical masks during a hypothetical influenza pandemic in the United States. Carias C, Rainisch G, Shankar M, Adhikari BB, Swerdlow DL, Bower WA, Pillai SK, Meltzer MI, Koonin LM. Clinical Infectious Diseases. 2015 May 1;60 Suppl 1:S42-51. 2015.

   

• Clinician beliefs and attitudes regarding use of respiratory protective devices and surgical masks for influenza. Pillai SK, Beekmann SE, Babcock HM, Pavia AT, Koonin LM, Polgreen PM. Health Security. 13(4):274-280. 2015.

• A conceptual framework for allocation of federally stockpiled ventilators during large-scale public health emergencies. Zaza S, Koonin LM, Ajao A, Nystrom SV, Branson R, Patel A, Bray B, Iademarco MF. Health Security 14(1):1-6. 2016.

• Koonin L, Baeza S, Cropley J, Simone K and Bogdan G. Planning for a coordinated network of nurse triage lines during an influenza pandemic: Critical role for poison control centers. Clin Tox 2013:51(7):697.

EBOLA

• Early identification and prevention of the spread of Ebola—United States. Van Beneden CA, Pietz H, Kirkcaldy RD, Koonin LM, Uyeki TM, Oster AM, Levy DA, Glover M, Arduino MJ, Merlin TL, Kuhar DT, Kosmos C, Bell BP. MMWR Supplement. 2016 Jul 8;65(3):75-84. 2016.

• Systems for rapidly detecting and treating persons with Ebola virus disease--United States. Koonin LM, Jamieson DJ, Jernigan JA, Van Beneden CA, Kosmos C, Harvey MC, Pietz H, Bertolli J, Perz JF, Whitney CG, Sheehan-Laufer Halpin A, Daley WR, Pesik N, Margolis GS, Tumpey A, Tappero J, Damon I.  CDC Morbidity and Mortality Weekly Report, 64(8). 2015.

   

• Infectious disease physician assessment of hospital preparedness for Ebola virus disease. Polgreen PM, Santibanez S, Koonin LM, Rupp ME, Beekmann SE, Del Rio C. Open Forum Infectious Diseases. 2015 Jun 18; 2(3):ofv087. 2015.

   

• US hospital preparedness for obstetrics patients with possible Ebola. Meaney-Delman D, Koonin LM, Jamieson DJ. American Journal of Obstetrics and Gynecology. 212(4):417-9. 2015.

   

ZIKA

• Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program. Romero L, Koonin LM, Zapata LB, Hurst S, Mendoza Z, Lathrop E with the Z-CAN Program Development. Working Group. American Journal of Public Health. 2018 Sep;108 (S3):S227-S230. 2018.

• Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016 Li R, Simmons KB, Bertolli J, Rivera-Garcia B, Cox S, Romero L, Koonin LM, Valencia-Prado M, Bracero N, Jamieson DJ, Barfield W, Moore CA, Mai CT, Korhonen LC, Frey MT, Perez-Padilla J, Torres-Muñoz R, Grosse SD. Emerging infectious Diseases. 23(1):74-82. 2017.

   

NOVEL STRATEGIES TO REDUCE SURGE ON HEALTHCARE FACILITIES

• CDC’S Flu on Call® Simulation: Testing a National Helpline for Use During an Influenza Pandemic. Koonin LM, Sliger K, Kerr J, Bullen-Austin L, Graeden E, Farris K, Ionta C, Krause D, and Patel A. Health Security. 2020:18(5).

• Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic Adhikari BB, Koonin LM, Mugambi ML, Sliger KD, Washington ML, Kahn EB, Meltzer MI. Health Security. 16(5):334-340. 2018.

• Facilitating access to antiviral medications and information during an influenza pandemic: engaging with the public on possible new strategies Fain BA, Koonin LM, Stoto MA, Shah UA, Cooper SR, Piltch-Loeb RN, Kellermann AL. Biosecurity and Bioterrorism. 12(1):8-19. 2014.

• Broadening access to medical care during a severe influenza pandemic: the CDC nurse triage line project Koonin LM, Hanfling D. Biosecurity and Bioterrorism. 11(1):75-80. 2013.

WORKSITE HEALTH PROMOTION

• A systematic review of selected interventions for worksite health promotion. The assessment of health risks with feedback. Soler RE, Leeks KD, Razi S, Hopkins DP, Griffith M, Aten A, Chattopadhyay SK, Smith SC, Habarta N, Goetzel RZ, Pronk NP, Richling DE, Bauer DR, Buchanan LR, Florence CS, Koonin L, MacLean D, Rosenthal A, Matson Koffman D, Grizzell JV, Walker AM with the Task Force on Community Preventive Services.  American Journal of Preventive Medicine. 38(2). S237–S262. 2010.

• Purchaser's guide to clinical preventive services; moving science into coverage. Campbell, KP, Lanza, A, Koonin LM and the National Business Group on Health and the Centers for Disease Control and Prevention. 2006